www.fdanews.com/articles/137991-fda-warns-abiomed-on-unauthorized-heart-pump-marketing
FDA Warns Abiomed on Unauthorized Heart Pump Marketing
June 29, 2011
Shares in Abiomed fell Tuesday after the company received a letter from the FDA accusing the company of marketing one of its Impella heart pumps without marketing clearance.
Mass High Tech
Mass High Tech